January 26, 2019 – 12:41 AMT
PanARMENIAN.Net – Recent studies have been associated with the regular use of non-steroidal anti-inflammatory drugs, such as aspirin, for longer survival in some head and neck cancer, Reported News Medical Today.
Researchers propose to have a clinical trial to test the effectiveness and safety of non-steroidal anti-inflammatory drugs (NSAIDs) for this purpose.
They suggest that the effect observed is probably due to NSAIDs that reduce prostaglandin E2, a molecule that stimulates inflammation.
A report on their findings is published in the Journal of Experimental Medicine.
Head and neck cancer is cancer that develops tumors in the nose, sinuses, larynx, throat and mouth.
In most cases, tumors arise in the flat, thin, squamous cells that form the tissue layer of the surfaces. For this reason, they are called the squamous cell carcinoma of the head and neck (HNSCCs).
In the United States, people with HNSCCs account for about 4% of all cancer patients. These types of cancer also tend to have a lower survival rate than many other species.
The main risk factors for HNSCC are tobacco use, heavy alcohol use, sun exposure, and human papillomavirus (HPV) infection.